ARTICLE | Top Story
Bioenvision submits clofarabine MAA
August 20, 2004 7:00 AM UTC
BIVN submitted an MAA to the EMEA for clofarabine to treat relapsed or refractory acute leukemias in children. The filing is based on data from two Phase II trials in children with relapsed or refract...